Pushing the Right Buttons
Improving Efficacy of Therapeutic DNA Vectors
Cannabinoid-Based Drugs Seek New High, Part II
Developers Anticipate Additional Approvals after FDA Nod for Epidiolex
Organs-on-Chips Take Flight
Initiative to Use Technology Aboard International Space Station Set to Begin
CAR T Cells Show Solid Progress
Tumors are Being Deprived of Cover by New CAR T-Cell Technologies
For full access to this article login to GEN Select now.
CROs Adapt to Meet Changing Paradigms
As Pharma Activities Narrow, Contract Research Organizations Rapidly Increase Their Offerings
- In its goal to advance safe, effective, and profitable drugs to market, the pharmaceutical industry has long acknowledged contract research as an essential resource. But as several CROs discussed at Select Biosciences’ recent “Pharma Outsourcing Congress”, the CRO-pharma relationship has been integrally changing in response to pharma’s new challenges ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.